Search

Your search keyword '"Crotti, Lia"' showing total 835 results

Search Constraints

Start Over You searched for: Author "Crotti, Lia" Remove constraint Author: "Crotti, Lia"
835 results on '"Crotti, Lia"'

Search Results

1. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients

3. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study

4. Clinical Management of Brugada Syndrome: Commentary From the Experts

5. Worldwide Survey of COVID-19–Associated Arrhythmias

6. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action

7. Abstract 16660: Precision Diagnosis of Hypertrophic Cardiomyopathy: A New Definition of Inappropriate Hypertrophy

9. An International Multicenter Evaluation of Type 5 Long QT Syndrome

13. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology

14. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases

16. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

19. Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.

20. Implantable loop recorders in patients with Brugada syndrome: the BruLoop study

21. Prognostic Value of Multiplexed Assays of Variant Effect and Automated Patch-clamping forKCNH2-LQTS Risk Stratification

24. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

25. Genetics of Adult and Fetal Forms of Long QT Syndrome

26. Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

27. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]

28. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study

29. Long and Short QT Syndromes

30. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

33. Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry

41. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]

42. [Rationale and significance of the Italian Network for Cardiac Amyloidosis]

43. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca

44. EN-452414-5 VENTRICULAR CONDUCTION IS A MARKER FOR ARRHYTHMIC RISK IN OVERLAP SODIUM CHANNEL DISEASE

45. From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow

46. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2

Catalog

Books, media, physical & digital resources